Center For Financial Planning, Inc. Gilead Sciences, Inc. Transaction History
Center For Financial Planning, Inc.
- $748 Million
- Q4 2024
A detailed history of Center For Financial Planning, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 138 shares of GILD stock, worth $15,184. This represents 0.0% of its overall portfolio holdings.
Number of Shares
138
Previous 138
-0.0%
Holding current value
$15,184
Previous $11,000
9.09%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
2,088Shares Held
1.02BCall Options Held
8.73MPut Options Held
9.63M-
Black Rock Inc. New York, NY121MShares$13.3 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA116MShares$12.7 Billion0.19% of portfolio
-
Capital World Investors Los Angeles, CA71.7MShares$7.89 Billion1.05% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.64 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.9MShares$6.38 Billion1.15% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $138B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...